MFN2 and metabolic dysfunction-associated steatohepatitis: The study found that the expression level of MFN2 protein decreased significantly in NASH patients, liver steatosis mice and NASH mice; another study found that MFN1 protein expression was significantly reduced in the liver of NAFLD mice [55,56].